The investor conference for innovators
The 2022 program will feature insights from top investors and biopharma executives by:
- Examining how the biopharma industry can accelerate drug discovery and manufacturing to prepare for future pandemics.
- Providing updates in hot therapeutic areas such as oncology, CNS, cell and gene therapy, rare disease.
- Exploring how COVID-19 accelerated the adoption of all things digital through the Digital Medicine & Medtech Showcase program.
- Showcasing the promise of early-stage innovation through the Seed Showcase program.
